For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Total revenue | - | 0* | - | |
| Research and development | 343,970 | 199,814* | 262,506 | |
| General and administrative | 101,252 | 36,748* | 52,763 | |
| Total operating expenses | 445,222 | 236,562* | 315,269 | |
| Loss from operations | -445,222 | -236,562* | -315,269 | |
| Interest income | 19,508 | 24,417* | 22,083 | |
| Interest expense | 12,197 | -10,053* | 11,428 | |
| Change in fair value of warrant liability and contingent earn-out shares | - | -13,582* | -592 | |
| Change in fair value of warrant liability | 15,788 | - | - | |
| Other expense, net | - | 9* | - | |
| Other income (expense), net | 117 | - | 0 | |
| Total non-operating income (expense), net | -8,594 | 20,879* | 10,063 | |
| Loss before income taxes | -453,816 | -215,683* | -305,206 | |
| Benefit from income taxes | - | 0* | - | |
| Net loss | -453,816 | -215,683* | -305,206 | |
| Unrealized loss on investments, net | - | -3,526* | 1,814 | |
| Comprehensive loss | - | -219,209 | -303,392 | |
| Basic EPS | -2.29 | -1.148 | -1.61 | |
| Diluted EPS | -2.29 | -1.148 | -1.61 | |
| Basic Average Shares | 198,098,047 | 191,026,746 | 189,231,562 | |
| Diluted Average Shares | 198,098,047 | 191,026,746 | 189,231,562 | |